Corporate News 12-Aug-21
Frontier Capital adjourns board meeting
To 14 August 2021
Frontier Capital has adjourned the meeting of the Board of Directors which was scheduled to be held on 12 August 2021. The meeting will now be held on 14 August 2021.
Previous News
Frontier Capital standalone net profit declines 92.11% in the March 2024 quarter
( Results - Announcements 29-May-24 17:43 )
Frontier Capital standalone net profit declines 25.00% in the December 2023 quarter
( Results - Announcements 14-Feb-24 15:48 )
Frontier Capital reports standalone net loss of Rs 0.75 crore in the December 2016 quarter
( Results - Announcements 20-Feb-17 14:45 )
Frontier Capital to announce Quarterly Result
( Corporate News - 02-Feb-23 10:53 )
Frontier Capital schedules board meeting
( Corporate News - 05-Nov-21 10:54 )
Frontier Capital to convene AGM
( Corporate News - 16-Sep-24 10:31 )
Frontier Capital to declare Quarterly Result
( Corporate News - 23-May-22 10:25 )
Frontier Capital reports standalone net loss of Rs 1.61 crore in the September 2016 quarter
( Results - Announcements 16-Nov-16 17:28 )
Frontier Capital reports standalone nil net profit/loss in the September 2015 quarter
( Results - Announcements 10-Nov-15 11:29 )
Frontier Capital reports consolidated net loss of Rs 0.07 crore in the September 2015 quarter
( Results - Announcements 10-Nov-15 11:28 )
Frontier Capital standalone net profit rises 1214.29% in the March 2017 quarter
( Results - Announcements 31-May-17 12:17 )
Other Stories
FAST India partners with Indegene to accelerate biotech innovation in India
03-Jul-25 11:01
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Shakti Pumps launches QIP issue
03-Jul-25 09:08
Back
Top
